化學(xué)仿制藥參比制劑目錄(第六十三批)國內(nèi)上市的原TofacitinibCitrateTablets/Xeljanz(尚杰)國內(nèi)上市原研99%(5ml)BELCHERPHARMACEUTICALSLLC品BempedoicAcidandEzetimibeTablets/NEXLIZET品氟[18F]妥西吡FlortaucipirF18injection/TAUVID品氟[18F]妥西吡FlortaucipirF18injection/TAUVID)品5ml:每ml含硫酸新霉素(按新霉素計)mg素品DowPharmaceuticalSciences未進(jìn)口原研藥品液(17AA-SF)PROSOL20%SULFITEFREEINPLASTICBAXTERHLTHCARE未進(jìn)口原研藥品—2——SafinamidemesylateTablets/XADAGO未進(jìn)口原研藥品SafinamidemesylateTablets/XADAGO未進(jìn)口原研藥品射液/對乙酰氨基酚甘露醇注射液 品射液/對乙酰氨基酚甘露醇注射液品GadoteridolInjection/ProHance279.3mg/mL(1.3965g/5mL)未進(jìn)口原研藥品GadoteridolInjection/ProHance279.3mg/mL(2.793g/10mL)未進(jìn)口原研藥品GadoteridolInjection/ProHance279.3mg/mL(4.1895g/15mL)未進(jìn)口原研藥品GadoteridolInjection/ProHance279.3mg/mL(5.586g/20mL)未進(jìn)口原研藥品GadoteridolInjection/ProHance279.3mg/mL(13.965g/50mL)未進(jìn)口原研藥品品RBHEALTHUSLLC品benateDimeglumineInjection/Multihance5.290GM/10ML (529MG/ML)未進(jìn)口原研藥品他汀鋅膠囊EzetimiberosuvastatinzincCholecomb未進(jìn)口原研藥品他汀鋅膠囊EzetimiberosuvastatinzincCholecomb未進(jìn)口原研藥品EzetimiberosuvastatinzincProterapiaHungaryLtd未進(jìn)口原研藥歐盟上市—3——他汀鋅膠囊hardcapsule/Cholecomb品膠gel/AMELUZacid品片CarbidopaandLevodopaTablets/SINEMETLP品KowaPharmaceuticalEuropeGmbH未進(jìn)口原研藥品KowaPharmaceuticalEuropeGmbH未進(jìn)口原研藥品KowaPharmaceuticalEuropeGmbH未進(jìn)口原研藥品片BisoprololletsConcorFumarate未進(jìn)口原研藥品緩釋片MetoprololSuccinateTablets未進(jìn)口原研藥品GALDERMA品漿PemirolastPotassiumDrySyrup/Alegysal未進(jìn)口原研藥品ジン(NOBELZIN)ノーベルファーマ株式會社(NobelPharmaCo.,Ltd)品ジン(NOBELZIN)ノーベルファーマ株式會社(NobelPharmaCo.,Ltd)品碘[123I]芐胍注射液未進(jìn)口原研藥品/BICARBON品—4——會社未進(jìn)口原研藥品OrallyDisintegratingTablets/ACTOSOD (武田テバ薬品株式會社)品注射液ClindamycinPhosphateInjection/DalacinS未進(jìn)口原研藥品未進(jìn)口原研藥品上海百特醫(yī)療用品有限經(jīng)審核確定的國外原研企業(yè)在中國境內(nèi)生產(chǎn)的藥品LILLYFRANCE/ELILILLYITALIAS.p.A.品增加持證商ELILILLYITALIAS.p.A.片AziendeChimicheRiuniteAngelini品增加持證商片AziendeChimicheRiuniteAngelini品增加持證商3x鈉計)MerckSeronoGmbH/Merck品增加持證商片品增加持證商—5——液品增加持證商5太陽ファルマ株式會社/アストラゼネカ株式會社品增加持證商:太陽ファルマ株式會社6品增加變更后持證商品增加持證商國際公認(rèn)的同增加持證商PADAGISUSLLC7Ltd(齊魯制藥有限公司)PHARMACEUTICAL國際公認(rèn)的同增加變更后持QILUTICALLTDActavisUK增加變更后持證商株式會社medicalLtd.增加持證商:株LidocaineandPrilocaineCream/Emla(恩納)AstraZenecaAB/AspenustraliaPty國內(nèi)上市的原研藥品增